An Observational Study to Learn More About How Safe Treatment With Rivaroxaban is in Children in Japan With Venous Thromboembolism
Conditions: Venous Thromboembolism Interventions: Drug: Rivaroxaban granules for oral suspension; Drug: Warfarin Sponsors: Bayer; Janssen Pharmaceutical Companies (formerly Johnson& Johnson Pharmaceutical Research& Development L.L.C.) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Child Development | Children | Coumadin | Japan Health | Learning | Research | Study | Thrombosis | Universities & Medical Training | Warfarin